Clinical Trials
Showing 1166 Clinical Trials-
Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain
Start Date: December 2022 Updated: June 2019
Tel-Aviv, IsraelKetamine
Phase 3
Unknown status
-
Ketamine for Relapse Prevention in Recurrent Depressive Disorder
Start Date: December 2022 Updated: January 2020
Dublin, IrelandKetamine
Phase 1
Terminated
-
Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache
Start Date: December 2022 Updated: December 2015
GHB
Phase 3
Unknown status
-
Start Date: December 2022 Updated: February 2018
San Antonio, Texas, USAKetamine
Not Applicable
Terminated
-
Evaluating Ketamine and Psychological Sequelae
Start Date: December 2022 Updated: August 2019
Bethesda, Maryland, USAKetamine
Completed
-
Start Date: December 2022 Updated: October 2018
Winnipeg, Manitoba, CanadaKetamine
Phase 4
Completed
-
Neuronal Correlates of Altered States of Consciousness
Start Date: December 2022 Updated: September 2015
Basel, Basel-Stadt, SwitzerlandLSD
Early Phase 1
Completed
-
Start Date: December 2022 Updated: April 2018
Saint Louis, Missouri, USAGHB
Not Applicable
Completed
-
Dose Finding Study of Single Dose GHB11L1 in Healthy Adults
Start Date: December 2022 Updated: January 2011
Vienna, AustriaGHB
Phase 2
Completed
-
Start Date: December 2022 Updated: January 2012
Bingham Farms, Michigan, USAGHB
Phase 2
Completed